Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study
2021 · Journal of Thoracic Oncology · 244 citations
https://doi.org/10.1016/j.jtho.2021.02.009
S
Seppo W. Langer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
333
Papers
6.3K
Citations
39
h-index
121
i10-index
Seppo W. Langer is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Neuroendocrine Tumor Research Advances & Lung Cancer Research Studies & Neuroblastoma Research and Treatments. The author has an h-index of 39, co-authored 284 publications.
ORCID: 0000-0001-9732-9192Papers by this author
worksDexrazoxane for the treatment of chemotherapy-related side effects
2014 · Cancer Management and Research · 105 citations
https://doi.org/10.2147/cmar.s47238
Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study
2015 · Annals of Surgical Oncology · 86 citations
https://doi.org/10.1245/s10434-015-5013-2
“EXHALE”: exercise as a strategy for rehabilitation in advanced stage lung cancer patients: a randomized clinical trial comparing the effects of 12 weeks supervised exercise intervention versus usual care for advanced stage lung cancer patients
2013 · BMC Cancer · 32 citations
https://doi.org/10.1186/1471-2407-13-477
Early initiated postoperative rehabilitation enhances quality of life in patients with operable lung cancer: Secondary outcomes from a randomized trial
2020 · Lung Cancer · 28 citations
https://doi.org/10.1016/j.lungcan.2020.06.023
Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy
1999 · British Journal of Cancer · 23 citations
https://doi.org/10.1038/sj.bjc.6690372
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat